NDC 17478-609

ZIOPTAN

Tafluprost

ZIOPTAN is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Akorn, Inc.. The primary component is Tafluprost.

Product ID17478-609_01a2a304-9308-44dd-9c0f-db4d24757f5b
NDC17478-609
Product TypeHuman Prescription Drug
Proprietary NameZIOPTAN
Generic NameTafluprost
Dosage FormSolution/ Drops
Route of AdministrationOPHTHALMIC
Marketing Start Date2014-11-26
Marketing CategoryNDA / NDA
Application NumberNDA202514
Labeler NameAkorn, Inc.
Substance NameTAFLUPROST
Active Ingredient Strength0 mg/.3mL
Pharm ClassesProstaglandin Analog [EPC],Prostaglandin Receptor Agonists [MoA],Increased Prostaglandin Activity [PE],Prostaglandins [CS]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 17478-609-10

1 POUCH in 1 CARTON (17478-609-10) > 10 VIAL, SINGLE-USE in 1 POUCH (17478-609-01) > .3 mL in 1 VIAL, SINGLE-USE
Marketing Start Date2017-11-26
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 17478-609-90 [17478060990]

ZIOPTAN SOLUTION/ DROPS
Marketing CategoryNDA
Application NumberNDA202514
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-11-26

NDC 17478-609-10 [17478060910]

ZIOPTAN SOLUTION/ DROPS
Marketing CategoryNDA
Application NumberNDA202514
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-11-26

NDC 17478-609-01 [17478060901]

ZIOPTAN SOLUTION/ DROPS
Marketing CategoryNDA
Application NumberNDA202514
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-11-26

NDC 17478-609-30 [17478060930]

ZIOPTAN SOLUTION/ DROPS
Marketing CategoryNDA
Application NumberNDA202514
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-11-26

Drug Details

Active Ingredients

IngredientStrength
TAFLUPROST.0045 mg/.3mL

OpenFDA Data

SPL SET ID:a3173c26-0e19-47af-a01c-3fc06b2700d1
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1244616
  • 1244611
  • UPC Code
  • 0317478609018
  • 0317478609308
  • Pharmacological Class

    • Prostaglandin Analog [EPC]
    • Prostaglandin Receptor Agonists [MoA]
    • Increased Prostaglandin Activity [PE]
    • Prostaglandins [CS]

    Medicade Reported Pricing

    17478060930 ZIOPTAN 0.0015% EYE DROPS

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "ZIOPTAN" or generic name "Tafluprost"

    NDCBrand NameGeneric Name
    17478-609ZIOPTANtafluprost
    82584-609ZIOPTANTafluprost
    0781-6184TafluprostTafluprost
    65302-062TafluprostTafluprost
    66993-429Tafluprost Ophthalmictafluprost

    Trademark Results [ZIOPTAN]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ZIOPTAN
    ZIOPTAN
    85091319 4161745 Live/Registered
    Merck Sharp & Dohme Corp.
    2010-07-23

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.